The metabolic syndrome: 'To be or not to be, that is the question

Diabetic Medicine

Volumn 23, Issue SUPPL. 3, 2006, Pages 16-18

  Grant, P J ^a   McGuire, D K ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN II ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; PIOGLITAZONE; TRIACYLGLYCEROL;

ADIPOCYTE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; FOOD INTAKE; GENETIC PREDISPOSITION; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PROGNOSIS; SEASONAL VARIATION; SHORT SURVEY;

DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 33745607572     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.1930_5.x     Document Type: Short Survey

References (17)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetologia 2005; 48: 1679-1683.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
5. Neel JV. Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'? Am J Hum Genet 1962; 14: 353-62.
6. Scott EM, Grant PJ. Neel revisited: the adipocyte, seasonality and type 2 diabetes. Diabetologia 2006 (in press).
7. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Heritability of features of the insulin resistance syndrome in a community based study of healthy families. Diabet Med 2002; 19: 994-999.
8. Mills GW, Avery PJ, McCarthy MI, Hattersley AT, Levy JC, Hitman GA et al. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 2004; 47: 732-738.
9. Lin H-F, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco R-L. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005; 48: 2006-2012.
10. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Organization 1999.
11. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
12. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome 2005. Available from http://www.idf.org Last accessed June 2005.
13. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214.
15. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
17. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005; 28: S4-S36.